Search Results - Hulse, G.

  • Showing 1 - 17 results of 17
Refine Results
  1. 1
    Mortality in heroin users 3 years after naltrexone implant or methadone maintenance treatment

    Mortality in heroin users 3 years after naltrexone implant or methadone maintenance treatment by Tait, Robert, Ngo, H., Hulse, G.

    Published 2008
    Get full text
  2. 2
    Assessing motivation to quit smoking in people with mental illness

    Assessing motivation to quit smoking in people with mental illness by Siru, R., Hulse, G., Tait, Robert

    Published 2009
    Get full text
  3. 3
    Hospital psychiatric comorbidity and its role in heroin dependence treatment outcomes using naltrexone implant or methadone maintenance

    Hospital psychiatric comorbidity and its role in heroin dependence treatment outcomes using naltrexone implant or methadone maintenance by Ngo, H., Tait, Robert, Hulse, G.

    Published 2011
    Get full text
  4. 4
    Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation

    Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation by Ngo, H., Tait, Robert, Hulse, G.

    Published 2008
    Get full text
  5. 5
    Risk factors for craving and relapse in heroin users treated with oral or implant naltrexone

    Risk factors for craving and relapse in heroin users treated with oral or implant naltrexone by Hulse, G., Ngo, H., Tait, Robert

    Published 2010
    Get full text
  6. 6
    The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: Review of human and animal data

    The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: Review of human and animal data by Farid, W., Dunlop, S., Tait, Robert, Hulse, G.

    Published 2008
    Get full text
  7. 7
    Motivation to quit smoking among hospitalised individuals with and without mental health disorders

    Motivation to quit smoking among hospitalised individuals with and without mental health disorders by Siru, R., Hulse, G., Khan, R., Tait, Robert

    Published 2010
    Get full text
  8. 8
    Improving clinical outcomes in treating heroin dependence: randomized, controlled trial of oral or implant naltrexone

    Improving clinical outcomes in treating heroin dependence: randomized, controlled trial of oral or implant naltrexone by Hulse, G., Morris, N., Arnold-Reed, D., Tait, Robert

    Published 2009
    Get full text
  9. 9
    Minor pathological changes are induced by naltrexone-poly(DL-lactide) implants in pregnant rats

    Minor pathological changes are induced by naltrexone-poly(DL-lactide) implants in pregnant rats by Farid, W., McCallum, D., Tait, Robert, Dunlop, S., Hulse, G.

    Published 2009
    Get full text
  10. 10
    Screening for hazardous alcohol use and dependence in psychiatric in-patients using the AUDIT questionnaire

    Screening for hazardous alcohol use and dependence in psychiatric in-patients using the AUDIT questionnaire by Hulse, G., Saunders, J., Roydhouse, R., Stockwell, Tim, Basso, M.

    Published 2000
    Get full text
  11. 11
    Maternally Administered Sustained-Release Naltrexone in Rats Affects Offspring Neurochemistry and Behaviour in Adulthood

    Maternally Administered Sustained-Release Naltrexone in Rats Affects Offspring Neurochemistry and Behaviour in Adulthood by Farid, W., Lawrence, A., Krstew, E., Tait, Robert, Hulse, G., Dunlop, S.

    Published 2012
    Get full text
  12. 12
    Blood naltrexone levels over time following naltrexone implant

    Blood naltrexone levels over time following naltrexone implant by Ngo, H., Arnold-Reed, D., Hansson, R., Tait, Robert, Hulse, G.

    Published 2008
    Get full text
  13. 13
    Erratum to “Emergency department based intervention with adolescent substance users: 10 year economic and health outcomes” [Drug Alcohol Depend. 165 (2016) 168–174] ((2016) 165 (168–174)(S037687161630151X)(10.1016/j.drugalcdep.2016.06.005))

    Erratum to “Emergency department based intervention with adolescent substance users: 10 year economic and health outcomes” [Drug Alcohol Depend. 165 (2016) 168–174] ((2016) 165 (16... by Tait, Robert, Teoh, L., Kelty, E., Geelhoed, E., Mountain, D., Hulse, G.

    Published 2016
    Get full text
  14. 14
    Emergency department based intervention with adolescent substance users: 10 year economic and health outcomes

    Emergency department based intervention with adolescent substance users: 10 year economic and health outcomes by Tait, Robert, Teoh, L., Kelty, E., Geelhoed, E., Mountain, D., Hulse, G.

    Published 2016
    Get full text
  15. 15
    24-Month effect of smoking cessation on cognitive function and brain structure in later life

    24-Month effect of smoking cessation on cognitive function and brain structure in later life by Almeida, O., Garrido, G., Alfonso, Helman, Hulse, G., Lautenschlager, N., Hankey, G., Flicker, L.

    Published 2011
    Get full text
  16. 16
    Biodegradability of naltrexone-poly(DL) lactide implants in vivo assessed under ultrasound in humans

    Biodegradability of naltrexone-poly(DL) lactide implants in vivo assessed under ultrasound in humans by Hulse, G., Low, V., Stalenberg, V., Morris, N., Thompson, R., Tait, Robert, Phan, C., Ngo, H., Arnold-Reed, D.

    Published 2008
    Get full text
  17. 17
    Changes in hospital and out-patient events and costs following implant naltrexone treatment for problematic alcohol use

    Changes in hospital and out-patient events and costs following implant naltrexone treatment for problematic alcohol use by Kelty, E., Hayes, L., O'Neil, G., Kyle, S., Jeffrey, G., O'Neil, G., Hendrie, Delia, Mukhtar, Syed Aqif, Hulse, G.

    Published 2014
    Get full text

Search Tools: